To amend the Internal Revenue Code of 1986 to provide that the vaccine excise tax shall apply to any vaccine against hepatitis A.

Amends the Internal Revenue Code to provide that the term "taxable vaccine" shall apply to any vaccine against hepatitis A manufactured or produced in the United States or brought into the United States for consumption, use, or warehousing, thus providing that the vaccine excise tax shall apply to such vaccines.